Discover key insights from Collegium Pharmaceutical's Q1 2025 earnings call: 23% revenue growth, Jornay PM's market success, sales force expansion & ...

Egham, UK - 6th May 2025 - Essential Pharma ("Essential” or "the Company”), a global pharmaceutical company developing and ...

Nick de Cent discusses the evolution of pharmaceutical sales, looking at what it takes for an organisation to be successful today in terms of its multi-channel marketing approach. For an industry ...

The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...

Q1 2025 Earnings Call Transcript May 9, 2025 Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter ...

Leaders from Salix Pharmaceuticals and Syneos Health Communications share their real-world journeys to becoming truly ...

Paysign's patient affordability segment is experiencing rapid growth with higher margins, and is expected to double revenue ...

Operator: Greetings and welcome to the Amphastar Pharmaceuticals First Quarter Earnings Call. At this time, all participants ...

Sales and operating profit growth, significant product acquisition completed, 11 new products, first deal outside Europe and graduation year passed January - March 2025 Consolidated sales during the ...

The heavily pre-treated patients showed median progression-free survival of 29 months, which meant their tumours didn’t get ...

Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 ...

Special Report: Dimerix has received the upfront payment of US$30 million (~A$48m) from Amicus Therapeutics after signing an ...